Rethinking the war on cancer

Lancet
Douglas Hanahan

Abstract

Some 40 years ago a metaphor was posed that cancer was such an insidious adversary that a declaration of war on the disease was justified. Although this statement was a useful inspiration for enlistment of resources, despite extraordinary progress in our understanding of disease pathogenesis, in most cases and for most forms of cancer this war has not been won. A second metaphor was about magic bullets--targeted therapies based on knowledge of mechanisms that were envisaged to strike with devastating consequences for the disease. The reality, however, is that targeted therapies are generally not curative or even enduringly effective, because of the adaptive and evasive resistance strategies developed by cancers under attack. In this Series paper, I suggest that, much like in modern warfare, the war on cancer needs to have a battlespace vision.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Oct 20, 2010·Nature Reviews. Clinical Oncology·Farah L RehmanAlan Ashworth
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 3, 2011·Nature Reviews. Drug Discovery·Denise A Chan, Amato J Giaccia
Mar 24, 2012·Cancer Cell·Douglas Hanahan, Lisa M Coussens
Mar 31, 2012·Science Translational Medicine·Bert Vogelstein, Kenneth W Kinzler
Mar 31, 2012·Science Translational Medicine·Steven A Rosenberg
Apr 4, 2012·Cancer Treatment Reviews·Malcolm R AlisonLinda J Nicholson
May 16, 2012·Cancer Discovery·Levi A Garraway, Pasi A Jänne
Jun 8, 2012·Nature Reviews. Cancer·Christoph Bock, Thomas Lengauer
Jul 12, 2012·Nature Biotechnology·Bissan Al-LazikaniPaul Workman
Aug 17, 2012·Future Oncology·Mark R LacknerJeff Settleman
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin N Bottsford-MillerAnil K Sood
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Jan 19, 2013·Science·Lisa M CoussensA Karolina Palucka
Feb 8, 2013·Lancet·Franco Cavalli
Mar 8, 2013·Science Translational Medicine·Harold Varmus, Harpal S Kumar
Mar 28, 2013·Science Signaling·Anne RoulstonGordon C Shore
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Oct 18, 2013·The Lancet Oncology·Ramon Luengo-FernandezRichard Sullivan
Nov 13, 2013·Cancers·Shinsaku TogoAkira Orimo
Dec 20, 2013·Lancet·Paolo Vineis, Christopher P Wild

❮ Previous
Next ❯

Citations

Jul 20, 2012·Journal of the National Cancer Institute·Michael W Vannier
Jul 12, 2014·BioMed Research International·Mariano Bizzarri, Alessandra Cucina
Sep 2, 2014·Nature Reviews. Cancer·Daniel W Stuckey, Khalid Shah
Jul 12, 2014·Médecine sciences : M/S·Carlos Sonnenschein, Ana M Soto
Jun 3, 2014·Lancet·Ian Haines
Nov 20, 2014·Future Medicinal Chemistry·Chao DingYuyang Jiang
Nov 23, 2015·Seminars in Cancer Biology·Keith I BlockMassimo Zollo
Jan 17, 2015·Expert Review of Proteomics·Gabriella PintoJasminka Godovac-Zimmermann
Jul 22, 2015·Proceedings of the National Academy of Sciences of the United States of America·Zhao-Rong LunFrancisco J Ayala
Feb 28, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Charlotte Vrinten, Jane Wardle
Dec 30, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas WiederMartin Röcken
May 23, 2015·Blood Reviews·Elie AzoulayUNKNOWN Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique (Grrr-OH)
Nov 27, 2015·Journal of Colloid and Interface Science·Longlong ZhangYuxia Luan
Jun 3, 2014·The Journal of Physiology·Michael J Joyner, Franklyn G Prendergast
Nov 27, 2015·Journal of Experimental & Clinical Cancer Research : CR·Margaretha A SkowronMichèle J Hoffmann
Sep 1, 2015·Cellular and Molecular Life Sciences : CMLS·Naomi E van der SligteEveline S J M de Bont
Jul 17, 2015·Cancer Medicine·Bingya LiuDezhong Joshua Liao
Aug 19, 2015·Journal of the National Cancer Institute·Carlos Sonnenschein, Ana M Soto
Mar 1, 2015·European Journal of Pharmacology·Seyyed Mortaza HaghgooIan M Adcock
Jul 2, 2014·Experimental and Molecular Pathology·Michael MelnickTina Jaskoll
Nov 5, 2014·Frontiers in Oncology·Sui Huang
Dec 11, 2014·Cancer Cell International·Carlos SonnenscheinAna M Soto
Jun 11, 2016·Acta Biotheoretica·Mariano Bizzarri, Alessandra Cucina
Jun 29, 2016·Diagnostic Pathology·Felix BehlingJens Schittenhelm
Jun 23, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Paramasivan PoornimaThomas Efferth
Jul 23, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Bernd Rosslenbroich
Aug 9, 2016·Progress in Biophysics and Molecular Biology·Carlos Sonnenschein, Ana M Soto
Aug 12, 2016·BMC Medical Genomics·Sunandini SharmaDario Ghersi
Apr 24, 2015·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Caroline A Bravo, Laurie Hoffman-Goetz
Sep 19, 2016·Seminars in Cancer Biology·Timur R SamatovUdo Schumacher
Oct 25, 2016·Trends in Pharmacological Sciences·Claudia NeulAnne T Nies
Nov 22, 2016·Healthcare·Tamara CadetPatricia Wilson
Jan 6, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won KimHo-Young Lee
Dec 9, 2016·Dose-response : a Publication of International Hormesis Society·Mohan Doss
Dec 2, 2017·Journal of Cell Communication and Signaling·Heinz Hammerlindl, Helmut Schaider
Jul 16, 2016·International Journal of Molecular Sciences·Jeffrey L PlattMarilia Cascalho
Feb 22, 2018·International Journal of Molecular Sciences·Marcella Regina CardosoSophie Françoise Mauricette Derchain
Jul 13, 2018·Biomaterials Science·Chenwei WuChuan Zhang
Mar 9, 2018·BMC Cancer·G T VondelingM H Rozenbaum
Apr 16, 2019·Journal of Neuroscience Research·Myrna A R Dent, Armando Aranda-Anzaldo
Apr 27, 2019·The Journal of Experimental Medicine·Birgit Ritter, Florian R Greten
Jun 22, 2019·Cellular and Molecular Life Sciences : CMLS·Leonardo Vinícius Monteiro de AssisAna Maria de Lauro Castrucci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Annals of Thoracic Surgery
K O LilleheiQ Kong
Endocrine-related Cancer
Valeria CoppolaDésirée Bonci
© 2021 Meta ULC. All rights reserved